BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7

• Press Releases

  Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025

  October 7, 2025

   · 

  5 min read
• Press Releases

  Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform

  October 7, 2025

   · 

  6 min read
• Press Releases

  Arcadia Medicine Announces FDA Clearance of IND Application for a Patented Form of MDMA

  October 7, 2025

   · 

  3 min read
• Press Releases

  Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities

  October 7, 2025

   · 

  5 min read
• Press Releases

  Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025

  October 7, 2025

   · 

  2 min read
• Press Releases

  CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B

  October 7, 2025

   · 

  7 min read
• Press Releases

  Alcresta Therapeutics Expands Executive Leadership to Drive Strategic Initiatives

  October 7, 2025

   · 

  4 min read
• Press Releases

  Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders

  October 7, 2025

   · 

  13 min read
• Press Releases

  FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

  October 7, 2025

   · 

  14 min read
• Press Releases

  Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa

  October 7, 2025

   · 

  6 min read